DEA Administrator Remarks
DEA Applauds the Repeal of the X-Waiver
January 17, 2023
|
DEA Administrator
Download Document
“In this moment, when the United States is suffering tens of thousands of opioid-related drug poisoning deaths every year, the DEA’s top priority is doing everything in our power to save lives,” said Administrator Milgram. “Medication for opioid use disorder helps those who are fighting to overcome substance use disorder by sustaining recovery and preventing overdoses. At DEA, our goal is simple: we want medication for opioid use disorder to be readily and safely available to anyone in the country who needs it. DEA applauds the repeal of the X-Waiver and all it will do to expand access to buprenorphine for those who need it.”